EANS-Adhoc: LifeWatch AG to announce Second Quarter 2009 Results on July 28, 2009 . Press release at 7:00 a.m. CEST . Analyst and media conference held in Zurich at 10:00 a.m. CEST . In

--------------------------------------------------------------------------------
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
distribution. The issuer is solely responsible for the content of this
announcement.
--------------------------------------------------------------------------------

quarterly report/Invitation to Analyst and Media Conference on Q2 09
Results on 28 July 2009

02.07.2009

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss
Exchange: LIFE) announces its results for the second quarter 2009 on
July 28, 2009. As expected, business continues to develop positively.
Due to the ongoing success of the wireless cardiac monitoring
LifeStar ACT services LifeWatch will report strong second quarter
results and present a positive outlook for 2009.

Press Release at 7:00 a.m. CEST (1:00 a.m. EST)

The results for the second quarter 2009 will be issued
internationally at 7:00 a.m. CEST.

Analyst and Media conference

LifeWatch will report in detail on the second quarter 2009 results at
an English-speaking analyst and media conference which takes place in
Zurich on

Tuesday, July 28, 2009; 10.00 a.m. CEST, at the Marriott Hotel
Zurich, Neumühlequai 42, 8001 Zurich/Switzerland

Please confirm your participation at the analyst/media conference by
returning the attached registration form by July 23, 2009.

International Conference Call/Audio Webcast at 2:00 p.m. CEST (8:00
a.m. EST)

For international participants a combined conference call and audio
webcast, accompanied by presentation visuals, is scheduled at 2:00 am
CEST (8:00 a.m. EST) that same day. Further information regarding the
audio webcast and respective technical requirements can be found in
the Investor Relations section of the LifeWatch website
www.lifewatch.com in due time. An archived version of the webcast
will remain available for download.

The local dial-in numbers for the conference call are as follows:

+41 (0)91 610 56 00 (Europe)
+44 (0)207 107 06 11 (UK)
+1 (1) 866 291 41 66 (USA - Toll-Free)

All participants should dial in at least 10 minutes prior to the
call. There is no PIN required to access the call.

Sign-up for customized E-mail alerts and documentation requests is
available at

http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All
statements other than statements of historical facts contained in
this press release, including statements regarding future results of
operations and financial position, business strategy and plans and
objectives for future operations, are forward- looking statements.
The words "believe," "may," "will," "estimate," "continue,"
"anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward- looking statements largely on current expectations and
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business
strategy, short term and long term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking
events and circumstances described may not occur and actual results
could differ materially and adversely from those anticipated or
implied in the forward- looking statements. All forward-looking
statements are based only on data available to LifeWatch AG at the
time of the issue of this press release. LifeWatch AG does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S.
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS. ANY
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.

end of ad-hoc-announcement

================================================================================
About LifeWatch AG

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss

Exchange (LIFE), Switzerland, is the leading healthcare technology
and solution company, specializing in advanced telehealth systems and
wireless cardiac monitoring services. LifeWatch services treat
high-risk and chronically ill patients, health conscious consumers
and wellness programs. LifeWatch has subsidiaries in the United
States, the Netherlands, Japan, the United Kingdom, Switzerland and
Israel. LifeWatch AG is the parent company of LifeWatch Services
Inc., a leading US-based cardiac monitoring service provider, and
LifeWatch Technologies Inc., a US-based manufacturer of
telecardiology products. www.lifewatch.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.de

Further inquiry note:

For further information please contact:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG

Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | Email kobibe@cardguard.com

Sensus Investor and Public Relations GmbH, Zürich:

Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade